A five-drug class model using routinely available clinical features to optimise prescribing in type 2 diabetes: a prediction model development and validation study. (2025)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(24)02617-5
PubMed Identifier: 40020703
Publication URI: http://europepmc.org/abstract/MED/40020703
Type: Journal Article/Review
Volume: 405
Parent Publication: Lancet (London, England)
Issue: 10480
ISSN: 0140-6736